GE Aerospace vs Illumina, Inc. — how do they compare? GE Aerospace trades at $307 (market cap $317.10B), while Illumina, Inc. trades at $266.99 (market cap $39.95B). The key difference: GE Aerospace is far larger — about 7.9× Illumina, Inc.'s market cap, and GE Aerospace pays a 0.62% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold GE Aerospace for 111 Days and Illumina, Inc. for 83 Days on average.
| GE | ILMN | |
|---|---|---|
Market Cap | $317.10B | $39.95B |
Volume | 6,320,106 | 3,169,503 |
Sector | Industrials | Health |
52-Week High | $381.22 | $293.69 |
52-Week Low | $273.25 | $91.00 |
Typical Hold Time | 111 Days | 83 Days |
Enterprise Value | $326.91B | $41.31B |
Dividend Yield | 0.62% | — |
Signals from Pluang's Aura AI — not financial advice
GE Aerospace trades at $305.62, down 1.22% amid broader market weakness, with technical indicators showing bearish momentum below key moving averages. Fundamentally, the company demonstrates strong profitability with 17.72% net margins and consistent earnings beats, though valuation multiples appear elevated. Recent news highlights the strategic $12 billion CPP acquisition to address supply chain constraints while maintaining robust shareholder returns through dividends and buybacks.
The outlook remains constructive given strong defense demand and operational execution, but high valuation and acquisition integration risks warrant caution. Analyst consensus is strongly bullish with a $409.60 price target representing 34% upside, though near-term technical pressure may persist until the Q3 earnings report provides clearer direction.
Illumina (ILMN) trades at $267.76, down 2.11% on the day but remains near its 52-week high. The stock exhibits a bullish technical trend with strong moving average signals, while recent earnings beats and a significant return to profitability in 2025 highlight fundamental improvement. Positive sentiment is fueled by S&P 500 inclusion and analyst upgrades, though high valuation ratios present a risk.
The outlook is cautiously optimistic, driven by sequencing growth and AI initiatives, but investors face risks from elevated valuations, competitive pressures, and potential margin volatility. The consensus price target of $241 suggests near-term downside from current levels despite a majority of analysts maintaining a Buy rating.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
General Electric Company is a globally diversified technology and financial services company. The Company's products and services include aircraft engines, power generation, water processing, and household appliances to medical imaging, business and consumer financing, and industrial products.
Read more on GE →Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →